Based in the United States, Brazosneuro is a startup.
Brazosneuro offers a proprietary Neural-Injury Assessment Test that uses blood biomarkers and genetic markers to objectively diagnose mild to moderate traumatic brain injury in the post-acute or chronic phase.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.